The influence of angiopoietin-like protein 3 on macrophages polarization and its effect on the podocyte EMT in diabetic nephropathy

被引:4
|
作者
Ma, Yanli [1 ]
Chen, Yu [1 ]
Xu, Hong [2 ]
Du, Ni [3 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 4, Dept Pediat, Sch Med, Shanghai, Peoples R China
[2] Fudan Univ, Dept Nephrol, Childrens Hosp, Shanghai, Peoples R China
[3] Chongqing Univ, Dept Nephrol, Gorges Hosp 3, Chongqing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
DN; Angptl3; podocyte; macrophage polarization; NLRP3; NLRP3; INFLAMMASOME; ACTIVATION; MUTATIONS; GLUCOSE; IMPACT;
D O I
10.3389/fimmu.2023.1228399
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Podocyte injury, which involves the podocyte epithelial-mesenchymal transition (EMT) process, is a crucial factor contributing to the progression of diabetic nephropathy (DN) and proteinuria. Our study aimed to examine the protective properties of Angiopoietin-like protein 3 (Angptl3) knockout on podocyte damage and macrophage polarization in DN mice and podocytes treated with HG. Furthermore, we also sought to investigate the underlying molecular mechanism responsible for these effects.Methods DN was induced in B6;129S5 mice through intraperitoneal injection of 40 mg/kg of streptozotocin (STZ). Subsequently, the changes in renal function, podocyte apoptosis, inflammatory factors (tumor necrosis factor-alpha [TNF-alpha], interleukin-6 [IL-6], and interleukin-1 beta [IL-1 beta]), IL-10, TGF-beta 1, IL-1Ra, IL-10Ra, and nephrin were evaluated. Moreover, we investigated the mechanism underlying the role of Angptl3 in macrophages polarization, podocyte injury, podocyte EMT.Results Our findings revealed that Angptl3 knockout significantly attenuated STZ or HG-induced renal dysfunction and podocyte EMT. In both in vivo and in vitro studies, Angptl3 knockout led to (1) promote the transformation of M1 type macrophages into M2 type macrophages; (2) amelioration of the reduced expression of nephrin, synaptopodin, and podocin; (3) inhibition of NLRP3 inflammasome activation and release of IL-1 beta; and (4) regulation of alpha-SMA expression via the macrophage polarization. (5) After HG treatment, there was an increase in pro-inflammatory factors and foot cell damage. These changes were reversed upon Angptle knockdown.Conclusion Our study suggests that the knockout of Angptl3 alleviates podocyte EMT and podocyte injury by regulating macrophage polarization.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia
    Ahmad, Zahid
    Pordy, Robert
    Rader, Daniel J.
    Gaudet, Daniel
    Ali, Shazia
    Gonzaga-Jauregui, Claudia
    Ponda, Manish P.
    Shumel, Brad
    Banerjee, Poulabi
    Dunbar, Richard L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (02) : 193 - 195
  • [42] Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
    Patrizia Tarugi
    Stefano Bertolini
    Sebastiano Calandra
    [J]. The Journal of Biomedical Research, 2019, 33 (02) : 73 - 81
  • [43] Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
    Kosmas, Constantine E.
    Bousvarou, Maria
    Sourlas, Andreas
    Papakonstantinou, Evangelia J.
    Genao, Edilberto Pella
    Uceta, Rogers Echavarria
    Guzman, Eliscer
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2022, 14 : 49 - 59
  • [44] Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
    Tarugi, Patrizia
    Bertolini, Stefano
    Calandra, Sebastiano
    [J]. JOURNAL OF BIOMEDICAL RESEARCH, 2019, 33 (02): : 73 - 81
  • [45] Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
    Ahmad, Zahid
    Banerjee, Poulabi
    Hamon, Sara
    Chan, Kuo-Chen
    Bouzelmat, Aurelie
    Sasiela, William J.
    Pordy, Robert
    Mellis, Scott
    Dansky, Hayes
    Gipe, Daniel A.
    Dunbar, Richard L.
    [J]. CIRCULATION, 2019, 140 (06) : 470 - 486
  • [46] Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
    Chen, Pei-Yi
    Gao, Wan-Yun
    Liou, Je-Wen
    Lin, Ching-Yen
    Wu, Ming-Jiuan
    Yen, Jui-Hung
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [47] Angiopoietin-like protein 3 inhibitors and contemporary unmet needs in lipid management
    Ying, Qidi
    Chan, Dick C.
    Watts, Gerald F.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 210 - 212
  • [48] Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children
    Wen, Fujie
    Liu, Junchao
    Dai, Rufeng
    Hong, Sha
    Ji, Baowei
    Liu, Jiaojiao
    Zhang, Jun
    Han, Xinli
    Lv, Qianying
    Liu, Jialu
    Shen, Qian
    Xu, Hong
    [J]. FRONTIERS IN PEDIATRICS, 2023, 11
  • [49] Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State
    Tikkanen, Emmi
    Minicocci, Ilenia
    Hallfors, Jenni
    Di Costanzo, Alessia
    D'Erasmo, Laura
    Poggiogalle, Eleonora
    Donini, Lorenzo Maria
    Wurtz, Peter
    Jauhiainen, Matti
    Olkkonen, Vesa M.
    Arca, Marcello
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (04) : 665 - 674
  • [50] Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor
    Inaba, T
    Matsuda, M
    Shimamura, M
    Takei, N
    Terasaka, N
    Ando, Y
    Yasumo, H
    Koishi, R
    Makishima, M
    Shimomura, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) : 21344 - 21351